Cytiva

Did you know? 75% of Cytiva’s carbon emissions come from our supply chain, a reminder of why supplier collaboration is key to our sustainability journey. Which means if we want to shrink our footprint, we’ve got to phone a friend - or 30 of them. So that’s exactly what we did. At our Supplier Sustainability Day, we brought together 30 suppliers to get on the same page: aligning on climate goals, setting expectations, and sparking action. From circular design to product transparency, these conversations weren’t just talk - they’re the blueprint for a low-carbon future. And yes, we’re building it together. Nefab Daniel Johansson

What if every single-use item had a second life? Meet STRAP – Solvent-Targeted Recovery and Precipitation – a breakthrough technology that’s flipping the script on plastic waste. Instead of ending up in landfills or incinerators, our single-use multilayer plastics are being transformed into high-performance materials. 🔄 This isn’t just recycling. This collaboration with the University of Wisconsin-Madison proves circular innovation at its finest – turning yesterday’s waste into tomorrow’s solutions. 💡 Ready to see how science is reshaping sustainability? 👉 Read the full story: https://okt.to/hIDgqC Xiaobo (Max) Dong, Ph.D., Karl Britt, PE, Louis Barrows

What do the top three biopharma ecosystems have in common? They’re not just investing in innovation – they’re building the infrastructure to deliver it. Switzerland, the UK, and South Korea lead the 2025 Global Biopharma Index. Each country is scaling digital tools, strengthening talent pipelines, and streamlining regulatory pathways to turn discovery into delivery. But the leaderboard is shifting fast. 𝗦𝗼𝘂𝘁𝗵 𝗞𝗼𝗿𝗲𝗮 jumped nine places in just two years. 𝗜𝗻𝗱𝗶𝗮 broke into the top 10. The 𝗨𝗦 dropped to fifth. Explore the full rankings and see how ecosystem strength is shaping commercial success. https://okt.to/pSeMsy are turning innovation into impact. 👉https://okt.to/5xjClV

Filtration can be one of the most overlooked steps in lab workflows - until it isn’t. When contaminants sneak in or experiments stall, the impact is immediate. As research advances, filtration should support - not slow - your progress. We collaborate with lab teams to build filtration strategies that are precise, adaptable, and ready to support the next breakthrough.👉https://okt.to/I6z0vE

Membrane proteins are notoriously tough to crack. But this workflow makes it faster to find the right conditions. Researchers at Evotec are using our ALIAS autosampler with aSEC/fSEC chromatography to screen 48 detergent and lipid combinations a day – helping them extract membrane proteins more efficiently and with less guesswork. It’s a smart setup: low-volume samples, fluorescence detection, and automation that fits inside a cold room. The result? A faster route to solubilization and a clearer path to purification. 📖 Read the full story: https://okt.to/viUOjY 👥 Featuring: Josephine Noakes, Claudia Grou, Francesco (Frank) Rao and Karthik Rajasekar from Evotec

We're #hiring! Join us at Cytiva and do something altogether life changing:

We're #hiring! Join us at Cytiva and do something altogether life changing:

Trick or threat? 🎃 It’s Halloween and the last day of Cybersecurity Awareness Month. Unlike Halloween, AI‑powered scams don’t take off the mask tomorrow. In biopharma, trust in suppliers and speed in decisions matter. Which scenario would disrupt your work the most?

Biopharma is innovating at record speed. So why isn’t the market keeping up? The 2025 Global Biopharma Index reveals a paradox: 💡 Breakthroughs in cell and gene therapies, mRNA platforms, and AI-driven discovery are accelerating. 📉 But nearly half of firms are behind on revenue and profitability targets. 📉 60% are falling short on market share goals. 📉 Time-to-market delays are widespread. We call it the 𝗶𝗻𝗻𝗼𝘃𝗮𝘁𝗶𝗼𝗻 𝗶𝗹𝗹𝘂𝘀𝗶𝗼𝗻 – when scientific progress outpaces the systems meant to deliver it. The data shows that success now depends on more than discovery. It requires strong ecosystems, digital maturity, and coordinated action across supply chains, talent, and regulation. Explore the full report to see how leaders are turning innovation into impact. 👉https://okt.to/94QPVg

𝗣𝗙𝗔𝗦 𝗶𝗻 𝘁𝗵𝗲 𝘀𝗼𝗶𝗹. 𝗠𝗶𝗰𝗿𝗼𝗽𝗹𝗮𝘀𝘁𝗶𝗰𝘀 𝗶𝗻 𝘁𝗵𝗲 𝘄𝗮𝘁𝗲𝗿. As scrutiny intensifies around soil contamination and sustainable agriculture, we’re seeing a shift: labs are rethinking workflows to reduce waste, protect instrumentation, and meet regulatory standards like EPA Method 1311 and 1633. And it starts with smarter filtration. Our latest FAQ guide breaks down the science behind soil testing – from choosing the right filter paper grade to understanding how extraction thimbles support pesticide analysis. 📘 Soil health matters. So does how you test it. 👉 https://okt.to/c4ql7i #PFAS #SoilHealth #EnvironmentalTesting #SustainableLabs #FiltrationMatters #CytivaScience #WhatmanFilters #LabEfficiency #EPACompliance